NCT01432587View on ClinicalTrials.gov

The Effect of Diflunisal on Familial Transthyretin Amyloidosis

CompletedOBSERVATIONAL
Enrollment

55

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Amyloidosis
Interventions
DRUG

Diflunisal

Film-coated tablet, 250 mg twice daily, orally for approximately 2 years

Trial Locations (3)

SE-941 28

Dept of Clinical Medicin, Ptieå Hospital, Piteå

SE-931 86

Dept of clinical medicin, Skellefteå Hospital, Skellefteå

SE-90185

Dept of Clinical Medicine, Umeå University Hospital, Umeå

All Listed Sponsors
lead

Umeå University

OTHER

NCT01432587 - The Effect of Diflunisal on Familial Transthyretin Amyloidosis | Biotech Hunter | Biotech Hunter